Stock Events

Stock Events

BioGaia 

$11.55
39
+$1.13+10.84%Friday 20:00

Statistics

Day High
10.42
Day Low
10.42
52W High
12.2
52W Low
10.24
Volume
1,000
Avg. Volume
1
Mkt Cap
0
P/E Ratio
28.17
Dividend Yield
1.5%
Dividend
0.17

Upcoming

Dividends

1.5%Dividend Yield
May 2026
$0.25
May 2026
$0.17
May 2025
$0.20
May 2025
$0.51
May 2024
$0.18
10Y Growth
1.71%
5Y Growth
1.2%
3Y Growth
7.6%
1Y Growth
-13.24%

Earnings

Feb 12Expected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q2 2026
Q3 2026
Next
0.07
0.08
0.1
0.12
Expected EPS
0.1160272
Actual EPS
N/A

Financials

33.76%Profit Margin
Profitable
2021
2022
2023
2024
2025
2026
36.02MRevenue
12.16MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BGLAF. It's not an investment recommendation.
NVIDIA
6
NVDA
Volvo AB
5
VOLV-B.ST
Investor AB
5
INVE-B.ST
Realty Income
4
O

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Daiichi Sankyo.
DSKYF
Mkt Cap32.06B
Danisco (DuPont Nutrition & Biosciences) offers probiotic strains that compete directly with BioGaia's products in the dietary supplement market.
Chervon Limited
CHRHF
Mkt Cap1.08B
Chr. Hansen Holding A/S specializes in probiotic and natural ingredient solutions for the food, nutritional, pharmaceutical, and agricultural industries, directly competing with BioGaia's probiotic offerings.
Novonesis AS
NVZMY
Mkt Cap30.33B
Novozymes provides bioinnovation, including probiotics that can be used in various applications, competing in the same space as BioGaia.
Kerry Group
KRYAF
Mkt Cap15.34B
Kerry Group offers nutritional and functional ingredients, including probiotics, that compete with BioGaia's range of products.
Herbalife
HLF
Mkt Cap1.37B
Herbalife Nutrition offers dietary supplements, including probiotics, competing in the same market as BioGaia.
Nusatrip
NUTR
Mkt Cap174.41M
Nutraceutical International Corporation manufactures and markets nutritional supplements, including probiotics, directly competing with BioGaia.
Amarin
AMRN
Mkt Cap509.13M
Amarin Corporation focuses on cardiovascular health products, but its interest in overall health could lead to expansion into areas like probiotics, making it a potential competitor to BioGaia.

About

BioGaia AB (publ), a Swedish enterprise founded in 1990 and headquartered in Stockholm, is dedicated to the worldwide development, marketing, and distribution of probiotic products renowned for their scientifically proven health advantages. The company operates through three primary divisions. Its Pediatrics segment offers various items such as drops, oral rehydration solutions, and gut health tablets, in addition to supplying cultures for integration into infant formula. The Adult Health segment provides gut health tablets and oral health lozenges, alongside furnishing cultures to licensees for use in dairy products. A third segment, "Other," specializes in packaging solutions. BioGaia's extensive product portfolio targets a range of health issues, including infantile colic and digestive health in children, antibiotic-associated and acute diarrhea, gingivitis, periodontal disease, general well-being, Helicobacter pylori bacterial infections (linked to gastric ulcers), and concerns related to low bone density. All of its offerings are sold exclusively under the BioGaia brand.
Show More
CEO
Theresa Agnew
Employees
251
Country
Sweden
ISIN
SE0017769995
WKN
000A3DL7T

Listings

OTC Link
US
BIOGY
STU
DE
BGLA.STU
MU
DE
BGL.MU
MU
DE
BGLA.MU

0 Comments

Share your thoughts

FAQs

What is BioGaia stock price today?▼
The current price of BGLAF is $11.55 USD — it has increased by +10.84% in the past 24 hours. Watch BioGaia stock price performance more closely on the chart.
What is BioGaia stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange BioGaia stocks are traded under the ticker BGLAF.
When is the next BioGaia earnings date?▼
BioGaia is going to release the next earnings report on February 12, 2027.
What were BioGaia earnings last quarter?▼
BGLAF earnings for the last quarter are 0.11 USD per share, whereas the estimation was 0.09 USD resulting in a +21.11% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is BioGaia revenue for the last year?▼
BioGaia revenue for the last year amounts to 36.02M USD.
What is BioGaia net income for the last year?▼
BGLAF net income for the last year is 12.16M USD.
Does BioGaia pay dividends?▼
Yes, BGLAF dividends are paid annual. The last dividend per share was 0.25 . As of today, Dividend Yield (FWD)% is 1.5%.
How many employees does BioGaia have?▼
As of November 7, 2026, the company has 251 employees.
In which sector is BioGaia located?▼
BioGaia operates in the Health & Wellness sector.
When did BioGaia complete a stock split?▼
The last stock split for BioGaia was on May 26, 2022 with a ratio of 2.5:1.
Where is BioGaia headquartered?▼
BioGaia is headquartered in Stockholm, Sweden.